Product Information | |
---|---|
Product Name | Human colon adenocarcinoma cell line (LS 174T luc) |
Specifications | 1*10^6 |
Storage and transportation | Dry ice preservation/T25 live cell transportation. |
Cell name | LS 174T-luc |
Cell morphology | Epithelioid, adherent cell |
Passage ratio | 1:2~1:4 |
species | Human |
Construction method | Virus Method |
Mycoplasma testing | negative |
Cultivation System | 90%DMEM+10% FBS |
The LS 174T luc human colon adenocarcinoma cell line offers a robust platform for cancer research and drug discovery featuring adherent epithelioid cells preserved under optimal conditions for transport and viability ensuring scientists can conduct high-quality experimental analysis with precise control over growth and experimentation
The Human Colon Adenocarcinoma Cell Line (LS 174T luc) is an invaluable tool in cancer research offering insights into the behavior of intestinal tumors while facilitating the development of targeted therapies This adherent epithelial cell line maintained at concentrations of 1*10^6 allows scientists to study cellular responses to various treatments under controlled conditions; thereby providing essential data that could lead to advances in cancer therapies
By utilizing dry ice preservation methods the LS 174T-luc cell line can be safely transported for live cell experimentation ensuring the integrity and viability of each sample upon arrival at the research facility With a composition of 90% DMEM and 10% FBS these cells are readily adaptable for experimental purposes enabling researchers to effectively investigate gene expression and signaling pathways that are pivotal in the progression of human colorectal cancer
Additionally the LS 174T luc cell line is instrumental in drug screening allowing for the evaluation of anti-cancer compounds in a relevant biological context With its ability to express luciferase researchers can also employ in vivo imaging techniques providing a powerful tool for monitoring tumor growth and response to treatment thus accelerating the discovery of new therapeutic strategies aimed at combating colon adenocarcinoma
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.